Richard Roxburgh: Young kiwi to be first to trial new muscular dystrophy drug

A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease.  The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy. Neurologist and trial lead Richard Roxburgh says the method is promising.   LISTEN ABOVESee omnystudio.com/listener for privacy information.